Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Open in API
Filings indexed 940 across all filing types
Latest filing 2023-11-24 Delisting Announcement
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
Delisting Announcement 2023
Delisting Announcement
2023-11-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It contains an announcement about a share consolidation (reverse stock split) approved at an extraordinary general meeting, and includes an exhibit of amended Articles of Association. The document is relatively short (2587 characters) and primarily serves as a regulatory announcement of corporate action rather than a full financial report or detailed filing. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document is relatively short (1992 characters) and primarily serves to furnish information rather than present a full report. According to the rules, such filings that provide updates or announcements without full financial data are classified as Regulatory Filings (RNS).
2023-11-13 English
MDxHealth - New Denominator (EN).pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights." It details a 1-for-10 reverse stock split (Share Consolidation), the resulting change in the number of outstanding shares, and updates on subscription rights and loan conversion rights. This action directly relates to the company's capital structure and share count. The most appropriate category among the provided definitions is 'Share Issue/Capital Change' (SHA), as a reverse stock split is a fundamental change to the capital structure. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific corporate action announcement, fitting SHA better than the general 'Regulatory Filings' (RNS).
2023-11-13 English
MDxHealth - New Denominator (FR).pdf
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing a corporate action: a 1-for-10 reverse stock split ('regroupement d'actions') and the resulting change in the number of outstanding shares and voting rights. It details the effective dates for trading the old versus the new shares and mentions the impact on American Depositary Shares (ADS). This action directly relates to the company's capital structure and share count. According to the definitions, 'Share Issue/Capital Change (Code: SHA)' covers announcements regarding new share issues, stock splits, or other capital changes. The content perfectly matches this description, as a reverse stock split is a capital structure change.
2023-11-13 French
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes announcements about amendments to the Articles of Association related to a capital increase and a de-listing approval by shareholders. The document is relatively short (2723 characters) and primarily serves as a regulatory announcement rather than a full financial report. It does not contain detailed financial statements or comprehensive analysis. The content focuses on corporate actions and regulatory compliance filings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-11-08 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.